News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
267 Results
Type
Article (43)
Company Profile (1)
Press Release (223)
Section
Business (116)
Deals (16)
Drug Development (37)
Job Trends (25)
News (145)
Policy (2)
Tag
Alliances (18)
Artificial intelligence (1)
Bankruptcy (1)
Best Places to Work (23)
Brain cancer (1)
Breast cancer (12)
Cancer (19)
CDC (1)
Clinical research (27)
Collaboration (1)
COVID-19 (2)
Cystic fibrosis (1)
Data (7)
Earnings (41)
Events (68)
Executive appointments (1)
FDA (3)
Funding (1)
Government (2)
Guidances (1)
Healthcare (5)
Immunology and inflammation (1)
Infectious disease (2)
IPO (12)
Job creations (1)
Layoffs (1)
Lung cancer (1)
Lymphoma (3)
Medical device (1)
Medtech (1)
Mergers & acquisitions (4)
Metabolic disorders (1)
Neuroscience (2)
NextGen: Class of 2025 (4)
Now hiring (1)
Obesity (1)
Parkinson's disease (2)
Patient recruitment (1)
People (57)
Pharmaceutical (1)
Phase I (17)
Phase II (12)
Phase III (6)
Pipeline (2)
Policy (1)
Preclinical (9)
Prostate cancer (3)
Radiopharmaceuticals (1)
Rare diseases (2)
Regulatory (3)
Series B (1)
Startups (11)
The Weekly (1)
Vaccines (1)
Venture capitalists (1)
Date
Last 7 days (1)
Last 30 days (8)
Last 365 days (50)
2025 (28)
2024 (44)
2023 (35)
2022 (34)
2021 (33)
2020 (31)
2019 (21)
2018 (12)
2017 (9)
2016 (8)
2015 (7)
2014 (4)
2013 (1)
Location
Asia (1)
California (1)
Canada (1)
Connecticut (26)
Europe (13)
Indiana (1)
Massachusetts (3)
New York (8)
North Carolina (1)
Northern California (1)
Pennsylvania (1)
Rhode Island (1)
United States (39)
267 Results for "arvinas".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arvinas to Present at Jefferies Global Healthcare Conference 2025
May 30, 2025
·
1 min read
Breast cancer
Pfizer, Arvinas Post Mixed Late-Stage Breast Cancer Data for Closely Watched PROTAC Drug
Vepdegestrant did not improve progression-free survival broadly but saw improvements in one specific patient cohort. Arvinas’ stock took a 43% tumble on the news, and analysts are downcast on the drug’s prospects.
March 11, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Arvinas Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 2, 2025
·
24 min read
Press Releases
Arvinas to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
April 29, 2025
·
1 min read
Press Releases
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the 2025 European Hematology Association (EHA) Annual Meeting
June 6, 2025
·
4 min read
Press Releases
Arvinas to Participate in Upcoming March 2025 Investor Conferences
March 5, 2025
·
1 min read
Press Releases
Arvinas and Pfizer’s Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer
June 2, 2025
·
17 min read
Press Releases
Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer
June 6, 2025
·
7 min read
Press Releases
Arvinas Announces Oral Presentation at 2025 International Conference on Alzheimer’s & Parkinson’s Diseases
March 28, 2025
·
4 min read
Press Releases
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at 2025 American Association for Cancer Research® (AACR) Annual Meeting
April 22, 2025
·
4 min read
1 of 27
Next
